Furthermore, in vivo experiments targeting xenograft tumour cells expressing EphB4 using anti-sense oligonucleotides and monoclonal antibodies have demonstrated significant inhibition of tumour growth [6, 10, 11, 16]. The gene discussed is EPHB4; the disease is neoplasm.